» Articles » PMID: 37468507

Biobank-scale Methods and Projections for Sparse Polygenic Prediction from Machine Learning

Overview
Journal Sci Rep
Specialty Science
Date 2023 Jul 19
PMID 37468507
Authors
Affiliations
Soon will be listed here.
Abstract

In this paper we characterize the performance of linear models trained via widely-used sparse machine learning algorithms. We build polygenic scores and examine performance as a function of training set size, genetic ancestral background, and training method. We show that predictor performance is most strongly dependent on size of training data, with smaller gains from algorithmic improvements. We find that LASSO generally performs as well as the best methods, judged by a variety of metrics. We also investigate performance characteristics of predictors trained on one genetic ancestry group when applied to another. Using LASSO, we develop a novel method for projecting AUC and correlation as a function of data size (i.e., for new biobanks) and characterize the asymptotic limit of performance. Additionally, for LASSO (compressed sensing) we show that performance metrics and predictor sparsity are in agreement with theoretical predictions from the Donoho-Tanner phase transition. Specifically, a future predictor trained in the Taiwan Precision Medicine Initiative for asthma can achieve an AUC of [Formula: see text] and for height a correlation of [Formula: see text] for a Taiwanese population. This is above the measured values of [Formula: see text] and [Formula: see text], respectively, for UK Biobank trained predictors applied to a European population.

Citing Articles

Polygenic height prediction for the Han Chinese in Taiwan.

Chang C, Chou C, Raben T, Chen S, Jong Y, Wu J NPJ Genom Med. 2025; 10(1):7.

PMID: 39910149 PMC: 11799370. DOI: 10.1038/s41525-025-00468-6.


Validation of GenProb-T1D and its clinical utility for differentiating types of diabetes in a biobank from a US healthcare system.

Billings L, Shi Z, Mulford A, Wei J, Tran H, Ashworth A J Diabetes Investig. 2024; 16(1):10-15.

PMID: 39171755 PMC: 11693536. DOI: 10.1111/jdi.14297.


EndoPRS: Incorporating Endophenotype Information to Improve Polygenic Risk Scores for Clinical Endpoints.

Kharitonova E, Sun Q, Ockerman F, Chen B, Zhou L, Cao H medRxiv. 2024; .

PMID: 38826253 PMC: 11142285. DOI: 10.1101/2024.05.23.24307839.

References
1.
Vattikuti S, Lee J, Chang C, Hsu S, Chow C . Applying compressed sensing to genome-wide association studies. Gigascience. 2014; 3:10. PMC: 4078394. DOI: 10.1186/2047-217X-3-10. View

2.
Bowdin S, Gilbert A, Bedoukian E, Carew C, Adam M, Belmont J . Recommendations for the integration of genomics into clinical practice. Genet Med. 2016; 18(11):1075-1084. PMC: 5557020. DOI: 10.1038/gim.2016.17. View

3.
Park L . Population-specific long-range linkage disequilibrium in the human genome and its influence on identifying common disease variants. Sci Rep. 2019; 9(1):11380. PMC: 6684625. DOI: 10.1038/s41598-019-47832-y. View

4.
Wang Y, Guo J, Ni G, Yang J, Visscher P, Yengo L . Theoretical and empirical quantification of the accuracy of polygenic scores in ancestry divergent populations. Nat Commun. 2020; 11(1):3865. PMC: 7395791. DOI: 10.1038/s41467-020-17719-y. View

5.
Azodi C, Bolger E, McCarren A, Roantree M, de Los Campos G, Shiu S . Benchmarking Parametric and Machine Learning Models for Genomic Prediction of Complex Traits. G3 (Bethesda). 2019; 9(11):3691-3702. PMC: 6829122. DOI: 10.1534/g3.119.400498. View